Literature DB >> 12175325

Bronchiectasis in indigenous children in remote Australian communities.

Anne B Chang1, Keith Grimwood, E Kim Mulholland, Paul J Torzillo.   

Abstract

The rates of bronchiectasis for Indigenous children from remote Australian communities are unacceptably high, with one study showing 14.7/1000 Aboriginal children. Children with bronchiectasis need to be identified early for optimisation of medical treatment. Under-reporting of cough is common. Bronchiectasis should be suspected in children with recurrent bronchitis or pneumonia, and when, despite appropriate therapy, pulmonary infiltrates or atelectasis persist 12 weeks beyond the index illness. During acute infective episodes, oral antibiotics and chest physiotherapy to clear the airways should produce prompt resolution; otherwise, hospitalisation is necessary. Management follows the cystic fibrosis model of regular review, encouragement of physical activity, optimising nutrition, maintenance of immunisation and avoidance of environmental toxicants, including passive smoke exposure. Successful management and prevention of bronchiectasis will require improvements in housing, nutrition, and education, as well as access to comprehensive healthcare services, with coordination between primary and hospital-based healthcare providers.

Entities:  

Mesh:

Year:  2002        PMID: 12175325     DOI: 10.5694/j.1326-5377.2002.tb04733.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  46 in total

1.  New Zealand national incidence of bronchiectasis "too high" for a developed country.

Authors:  J Twiss; R Metcalfe; E Edwards; C Byrnes
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

Review 2.  Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2017-09-27

Review 3.  Culture-specific programs for children and adults from minority groups who have asthma.

Authors:  Gabrielle B McCallum; Peter S Morris; Ngiare Brown; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2017-08-22

4.  Exploring cross-sectional associations between common childhood illness, housing and social conditions in remote Australian Aboriginal communities.

Authors:  Ross Bailie; Matthew Stevens; Elizabeth McDonald; David Brewster; Steve Guthridge
Journal:  BMC Public Health       Date:  2010-03-20       Impact factor: 3.295

5.  Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

Authors:  Gregory J Redding; Rosalyn J Singleton; Patricia C Valery; Hayley Williams; Keith Grimwood; Peter S Morris; Paul J Torzillo; Gabrielle B McCallum; Lori Chikoyak; Robert C Holman; Anne B Chang
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

Review 6.  Pneumococcal vaccines for children and adults with bronchiectasis.

Authors:  Christina C Chang; Rosalyn J Singleton; Peter S Morris; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

7.  Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand.

Authors:  K Grimwood; C Cohet; F J Rich; S Cheng; C Wood; N Redshaw; C W Cunningham; N Pearce; J R Kirman
Journal:  Epidemiol Infect       Date:  2008-01-04       Impact factor: 2.451

8.  Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis.

Authors:  J Twiss; A W Stewart; C A Byrnes
Journal:  Thorax       Date:  2006-02-07       Impact factor: 9.139

9.  Mucoid nitrate-negative Moraxella nonliquefaciens from three patients with chronic lung disease.

Authors:  Jennifer M Davis; Margaret J Whipp; Christopher Ashhurst-Smith; Jim C DeBoer; Margaret M Peel
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 10.  The pathophysiology of bronchiectasis.

Authors:  Paul T King
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.